Getting To Know The Anxious Brain | Inaugural Lecture by Professor Oliver Robinson
Oliver Robinson is Professor of Neuroscience and Mental Health at the Institute of Cognitive Neuroscience. He obtained his undergraduate degree in Neuroscience and PhD in Psychiatry and Neuroscience from the University of Cambridge. He did his postdoctoral training at the National Institute of Mental Health, Bethesda MD, USA and has been at UCL since 2013, first as an MRC CDA fellow and then as an MRC Senior Non Clinical fellow. Anxiety is something we all experience. It’s a healthy response that gets us primed and ready to avoid potential danger. But it can also become cripplingly debilitating, leading people to avoid engaging in things they find enjoyable. Professor Oliver Robinson will discuss his research trying to understand the cognitive and computational neuroscience of anxiety. He will discuss the use of unexpected shocks as a translational probe of anxiety and these findings relate to findings in clinical populations. He will discuss how our current treatments work, and where the field might go next to provide better treatment for those that currently fall through the gaps.
Oliver Robinson is Professor of Neuroscience and Mental Health at the Institute of Cognitive Neuroscience. He obtained his undergraduate degree in Neuroscience and PhD in Psychiatry and Neuroscience from the University of Cambridge. He did his postdoctoral training at the National Institute of Mental Health, Bethesda MD, USA and has been at UCL since 2013, first as an MRC CDA fellow and then as an MRC Senior Non Clinical fellow. Anxiety is something we all experience. It’s a healthy response that gets us primed and ready to avoid potential danger. But it can also become cripplingly debilitating, leading people to avoid engaging in things they find enjoyable. Professor Oliver Robinson will discuss his research trying to understand the cognitive and computational neuroscience of anxiety. He will discuss the use of unexpected shocks as a translational probe of anxiety and these findings relate to findings in clinical populations. He will discuss how our current treatments work, and where the field might go next to provide better treatment for those that currently fall through the gaps.